These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24902337)

  • 1. [Molecular genetics of intractable epilepsies].
    Kato M
    No To Hattatsu; 2014 May; 46(3):191-4. PubMed ID: 24902337
    [No Abstract]   [Full Text] [Related]  

  • 2. Determining the best candidates for next-generation sequencing-based gene panel for evaluation of early-onset epilepsy.
    Lee J; Lee C; Ki CS; Lee J
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1376. PubMed ID: 32613771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a cohort of 73 patients with infantile spasms syndrome.
    Boutry-Kryza N; Labalme A; Ville D; de Bellescize J; Touraine R; Prieur F; Dimassi S; Poulat AL; Till M; Rossi M; Bourel-Ponchel E; Delignières A; Le Moing AG; Rivier C; des Portes V; Edery P; Calender A; Sanlaville D; Lesca G
    Eur J Med Genet; 2015 Feb; 58(2):51-8. PubMed ID: 25497044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies.
    Zhou P; He N; Zhang JW; Lin ZJ; Wang J; Yan LM; Meng H; Tang B; Li BM; Liu XR; Shi YW; Zhai QX; Yi YH; Liao WP
    Genes Brain Behav; 2018 Nov; 17(8):e12456. PubMed ID: 29314583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncommon Treatable Genetic Epileptic Encephalopathies.
    Kamate M; Detroja M
    Indian Pediatr; 2019 May; 56(5):427-428. PubMed ID: 31102386
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of the epilepsies.
    Gutierrez-Delicado E; Serratosa JM
    Curr Opin Neurol; 2004 Apr; 17(2):147-53. PubMed ID: 15021241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders.
    Wolff M; Johannesen KM; Hedrich UBS; Masnada S; Rubboli G; Gardella E; Lesca G; Ville D; Milh M; Villard L; Afenjar A; Chantot-Bastaraud S; Mignot C; Lardennois C; Nava C; Schwarz N; Gérard M; Perrin L; Doummar D; Auvin S; Miranda MJ; Hempel M; Brilstra E; Knoers N; Verbeek N; van Kempen M; Braun KP; Mancini G; Biskup S; Hörtnagel K; Döcker M; Bast T; Loddenkemper T; Wong-Kisiel L; Baumeister FM; Fazeli W; Striano P; Dilena R; Fontana E; Zara F; Kurlemann G; Klepper J; Thoene JG; Arndt DH; Deconinck N; Schmitt-Mechelke T; Maier O; Muhle H; Wical B; Finetti C; Brückner R; Pietz J; Golla G; Jillella D; Linnet KM; Charles P; Moog U; Õiglane-Shlik E; Mantovani JF; Park K; Deprez M; Lederer D; Mary S; Scalais E; Selim L; Van Coster R; Lagae L; Nikanorova M; Hjalgrim H; Korenke GC; Trivisano M; Specchio N; Ceulemans B; Dorn T; Helbig KL; Hardies K; Stamberger H; de Jonghe P; Weckhuysen S; Lemke JR; Krägeloh-Mann I; Helbig I; Kluger G; Lerche H; Møller RS
    Brain; 2017 May; 140(5):1316-1336. PubMed ID: 28379373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood.
    Mercimek-Mahmutoglu S; Patel J; Cordeiro D; Hewson S; Callen D; Donner EJ; Hahn CD; Kannu P; Kobayashi J; Minassian BA; Moharir M; Siriwardena K; Weiss SK; Weksberg R; Snead OC
    Epilepsia; 2015 May; 56(5):707-16. PubMed ID: 25818041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.
    Zara F; Specchio N; Striano P; Robbiano A; Gennaro E; Paravidino R; Vanni N; Beccaria F; Capovilla G; Bianchi A; Caffi L; Cardilli V; Darra F; Bernardina BD; Fusco L; Gaggero R; Giordano L; Guerrini R; Incorpora G; Mastrangelo M; Spaccini L; Laverda AM; Vecchi M; Vanadia F; Veggiotti P; Viri M; Occhi G; Budetta M; Taglialatela M; Coviello DA; Vigevano F; Minetti C
    Epilepsia; 2013 Mar; 54(3):425-36. PubMed ID: 23360469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted capture and sequencing for detection of mutations causing early onset epileptic encephalopathy.
    Kodera H; Kato M; Nord AS; Walsh T; Lee M; Yamanaka G; Tohyama J; Nakamura K; Nakagawa E; Ikeda T; Ben-Zeev B; Lev D; Lerman-Sagie T; Straussberg R; Tanabe S; Ueda K; Amamoto M; Ohta S; Nonoda Y; Nishiyama K; Tsurusaki Y; Nakashima M; Miyake N; Hayasaka K; King MC; Matsumoto N; Saitsu H
    Epilepsia; 2013 Jul; 54(7):1262-9. PubMed ID: 23662938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lacosamide for SCN2A-related intractable neonatal and infantile seizures.
    Flor-Hirsch H; Heyman E; Livneh A; Reish O; Watemberg N; Litmanovits I; Ben Sason Lilli A; Lev D; Lerman Sagie T; Bassan H
    Epileptic Disord; 2018 Oct; 20(5):440-446. PubMed ID: 30361185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
    Millichap JJ; Miceli F; De Maria M; Keator C; Joshi N; Tran B; Soldovieri MV; Ambrosino P; Shashi V; Mikati MA; Cooper EC; Taglialatela M
    Epilepsia; 2017 Jan; 58(1):e10-e15. PubMed ID: 27861786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoclonic epilepsy evolved into West syndrome: a patient with a novel de novo KCNQ2 mutation.
    Samanta D; Ramakrishnaiah R; Willis E; Frye RE
    Acta Neurol Belg; 2015 Sep; 115(3):475-8. PubMed ID: 25092550
    [No Abstract]   [Full Text] [Related]  

  • 14. De novo mutations in epilepsy.
    Saitsu H; Matsumoto N
    Dev Med Child Neurol; 2011 Sep; 53(9):806-807. PubMed ID: 21631463
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic testing of epileptic encephalopathies of infancy: an approach.
    Sharma S; Prasad AN
    Can J Neurol Sci; 2013 Jan; 40(1):10-6. PubMed ID: 23250121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo R853Q mutation of SCN2A gene and West syndrome.
    Samanta D; Ramakrishnaiah R
    Acta Neurol Belg; 2015 Dec; 115(4):773-6. PubMed ID: 25772804
    [No Abstract]   [Full Text] [Related]  

  • 17. Infantile Epileptic Encephalopathy Associated With SCN2A Mutation Responsive to Oral Mexiletine.
    Foster LA; Johnson MR; MacDonald JT; Karachunski PI; Henry TR; Nascene DR; Moran BP; Raymond GV
    Pediatr Neurol; 2017 Jan; 66():108-111. PubMed ID: 27867041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
    Di Meglio C; Lesca G; Villeneuve N; Lacoste C; Abidi A; Cacciagli P; Altuzarra C; Roubertie A; Afenjar A; Renaldo-Robin F; Isidor B; Gautier A; Husson M; Cances C; Metreau J; Laroche C; Chouchane M; Ville D; Marignier S; Rougeot C; Lebrun M; de Saint Martin A; Perez A; Riquet A; Badens C; Missirian C; Philip N; Chabrol B; Villard L; Milh M
    Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a.
    Calhoun JD; Hawkins NA; Zachwieja NJ; Kearney JA
    Epilepsia; 2016 Jun; 57(6):e103-7. PubMed ID: 27112236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autism spectrum disorders and epilepsy].
    Andoh M; Ikegaya Y; Koyama R
    Nihon Yakurigaku Zasshi; 2016 Aug; 148(2):121-2. PubMed ID: 27478051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.